[Comment] Combining chemotherapy and immunotherapy for advanced anal cancer: are we ready?

March, 03, 2024 | Select Oncology Journal Articles

Advanced squamous cell carcinoma of the anus is a rare disease with few established treatment options. To date, a combination of platinum-based chemotherapy with taxane or fluorouracil is the standard of care as first-line treatment.1–3 In the refractory setting, immune checkpoint inhibitors have shown antitumour activity in a subset of patients. Thus, the use of immunotherapy in earlier lines of therapy in addition to a chemotherapy backbone might represent an appealing treatment strategy.4

For Additional News from OncWeekly – Your Front Row Seat To The Future of Cancer Care –




Sign up for our emails

Trusted insights straight to your inbox and get the latest updates from OncWeekly

Privacy Policy